the 503B thing finally clicked for me and I want to write it down
the 503B thing finally clicked for me and I want to write it down. Change my mind, genuinely — I have no stake in being right about this.
Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.
The intake asked me three questions and none of them were about my history. That told me everything I needed to know about the model.
Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot.
Please do not ask me what dose you should be on. I genuinely do not know and neither does anyone else here.
best — the order this archive was captured in
Compounded preparations are not approved products and carry no bioequivalence claim. That is a statement about regulatory category, not about quality.
Asked for potency testing on the finished preparation. They had it. I had assumed they would not.
Asked for potency testing on the finished preparation.
Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.
503A or 503B — do you know which?
503A is patient-specific, 503B is outsourcing facility, they are not the same thing
potency testing on the finished preparation is the thing to ask for
Asked for the beyond-use date basis and got a real answer with a stability reference attached. Not universal, apparently.
Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.
salt forms are the recurring argument and the answer is boring
Yes — asking which facility, by name, is the single most useful question and most clinics will answer it.
[deleted]
That figure is the starting material purity, not the finished preparation potency. Two different tests.
Disagree — a 503B being registered does not make its preparations equivalent to an approved product. Different regulatory category entirely.
a 503B has to register and report, so there is a paper trail to ask for
Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.
shortage status changes and the whole arrangement changes with it
the label on a compounded vial is a legal document, read it
Disagree — a 503B being registered does not make its preparations equivalent to an approved product.
Agreed — and the follow-up question is what the beyond-use date is based on.
a telehealth intake that asks nothing has told you what it is
Asked which facility and got a name straight away. Looked it up, found the registration, felt considerably better about the whole thing.
Kept the label from every vial. When the shortage status changed, having the paper trail made the conversation much shorter.
Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label.
if a clinic will not name the facility, that is your answer
Who is the prescriber, and are they the same organisation as the pharmacy?
ask what the beyond-use date is based on
- 1Disagree — a 503B being registered does not make its preparations equivalent…8 comments in this branch · started by u/usp_appendix
- 2Asked for the beyond-use date basis and got a real answer with a stability…6 comments in this branch · started by u/camila_sandvik